Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2024

Open Access 01-12-2024 | Aortic Valve Replacement | Research

Outcomes in patients with aortic stenosis and severely reduced ejection fraction following surgical aortic valve replacement and transcatheter aortic valve replacement

Authors: Eric R. Bain, Bistees George, Syed H. Jafri, Roopa A. Rao, Anjan K. Sinha, Maya E. Guglin

Published in: Journal of Cardiothoracic Surgery | Issue 1/2024

Login to get access

Abstract

Background

Patients with severe aortic stenosis (AS) and left ventricular (LV) dysfunction demonstrate improvement in left ventricular injection fraction (LVEF) after aortic valve replacement (AVR). The timing and magnitude of recovery in patients with very low LVEF (≤ 25%) in surgical or transcatheter AVR is not well studied.

Objective

Determine clinical outcomes following transcatheter aortic valve replacement (TAVR) and surgical aortic valve repair (SAVR) in the subset of patients with severely reduced EF ≤ 25%.

Methods

Single-center, retrospective study with primary endpoint of LVEF 1-week following either procedure. Secondary outcomes included 30-day mortality and delayed postprocedural LVEF. T-test was used to compare variables and linear regression was used to adjust differences among baseline variables.

Results

83 patients were enrolled (TAVR = 56 and SAVR = 27). TAVR patients were older at the time of procedure (TAVR 77.29 ± 8.69 vs. SAVR 65.41 ± 10.05, p < 0.001). One week post procedure, all patients had improved LVEF after both procedures (p < 0.001). There was no significant difference in LVEF between either group (TAVR 33.5 ± 11.77 vs. SAVR 35.3 ± 13.57, p = 0.60). Average LVEF continued to rise and increased by 101% at final follow-up (41.26 ± 13.70). 30-day mortality rates in SAVR and TAVR were similar (7.4% vs. 7.1%, p = 0.91).

Conclusion

Patients with severe AS and LVEF ≤ 25% have a significant recovery in post-procedural EF following AVR regardless of method. LVEF doubled at two years post-procedure. There was no significant difference in 30-day mortality or mean EF recovery between TAVR and SAVR.

Trial registration

Indiana University institutional review board granted approval for above study numbered 15,322.
Literature
3.
go back to reference Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. Circulation. 2008;118:e523–661.PubMed Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. Circulation. 2008;118:e523–661.PubMed
4.
go back to reference Smith CR, Leon MB, Mack MJ, et al. For PARTNER trial investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed Smith CR, Leon MB, Mack MJ, et al. For PARTNER trial investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed
5.
go back to reference George CM, Siontis F, Praz T, Pilgrim D, Mavridis S, Verma G, Salanti L, Søndergaard P, Jüni S, Windecker. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J, 37, Issue 47, 14 December 2016, Pages 3503–12, https://doi.org/10.1093/eurheartj/ehw225 George CM, Siontis F, Praz T, Pilgrim D, Mavridis S, Verma G, Salanti L, Søndergaard P, Jüni S, Windecker. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J, 37, Issue 47, 14 December 2016, Pages 3503–12, https://​doi.​org/​10.​1093/​eurheartj/​ehw225
7.
go back to reference Gleason TG, Reardon MJ, Popma JJ, et al. 5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018;72:2687–96.CrossRefPubMed Gleason TG, Reardon MJ, Popma JJ, et al. 5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018;72:2687–96.CrossRefPubMed
8.
go back to reference Furer A, Chen S, Redfors B, et al. / effect of baseline left ventricular ejection fraction on 2-year outcomes after transcatheter aortic valve replacement: analysis of the PARTNER 2 trials. Circulation: Heart Fail. 2019;12:8. Furer A, Chen S, Redfors B, et al. / effect of baseline left ventricular ejection fraction on 2-year outcomes after transcatheter aortic valve replacement: analysis of the PARTNER 2 trials. Circulation: Heart Fail. 2019;12:8.
9.
go back to reference Passeri JJ, Elmariah S, Xu K, Inglessis I, Baker JN, Alu M, Kodali S, Leon MB, Svensson LG, Pibarot P, Fearon WF, Kirtane AJ, Vlahakes GJ, Palacios IF, Douglas PS. PARTNER investigators. Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low. EF Heart. 2015;101:463–71. https://doi.org/10.1136/heartjnl-2014-306737CrossRefPubMed Passeri JJ, Elmariah S, Xu K, Inglessis I, Baker JN, Alu M, Kodali S, Leon MB, Svensson LG, Pibarot P, Fearon WF, Kirtane AJ, Vlahakes GJ, Palacios IF, Douglas PS. PARTNER investigators. Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low. EF Heart. 2015;101:463–71. https://​doi.​org/​10.​1136/​heartjnl-2014-306737CrossRefPubMed
10.
go back to reference Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1356–63.CrossRefPubMed Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1356–63.CrossRefPubMed
11.
go back to reference Mihaljevic T, Nowicki ER, Rajeswaran J, et al. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg. 2008;135:1270–8.CrossRefPubMed Mihaljevic T, Nowicki ER, Rajeswaran J, et al. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg. 2008;135:1270–8.CrossRefPubMed
13.
go back to reference O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP. The Society of thoracic surgeons 2008 cardiac surgery risk models: part 2–isolated valve surgery. Ann Thorac Surg. 2009;88:S23–42.CrossRefPubMed O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP. The Society of thoracic surgeons 2008 cardiac surgery risk models: part 2–isolated valve surgery. Ann Thorac Surg. 2009;88:S23–42.CrossRefPubMed
14.
go back to reference Baron SJ, Arnold SV, Herrmann HC, Holmes DR Jr., Szeto WY, Allen KB, Chhatriwalla AK, Vemulapali S, O’Brien S, Dai D, Cohen DJ. Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement. J Am Coll Cardiol. 2016 May 24;67(20):2349–58. [20] S. Elmariah, I.F. Palacios, T. McAndrew, I. Hueter, I. Inglessis, J.N. Baker, S. Kodali. Baron SJ, Arnold SV, Herrmann HC, Holmes DR Jr., Szeto WY, Allen KB, Chhatriwalla AK, Vemulapali S, O’Brien S, Dai D, Cohen DJ. Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement. J Am Coll Cardiol. 2016 May 24;67(20):2349–58. [20] S. Elmariah, I.F. Palacios, T. McAndrew, I. Hueter, I. Inglessis, J.N. Baker, S. Kodali.
15.
go back to reference Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kadota K, Izumi C, Nakatsuma K, Sasa T, Watanabe H, Kuwabara Y, Makiyama T, Ono K, Shizuta S, Kato T, Saito N, Minatoya K, Kimura T. CURRENT AS Registry investigators, prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis, JACC Cardiovasc. Interv. 2018;11(2):145–57. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kadota K, Izumi C, Nakatsuma K, Sasa T, Watanabe H, Kuwabara Y, Makiyama T, Ono K, Shizuta S, Kato T, Saito N, Minatoya K, Kimura T. CURRENT AS Registry investigators, prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis, JACC Cardiovasc. Interv. 2018;11(2):145–57.
16.
go back to reference Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, Douglas PS, Fearon WF, Kirtane AJ, Maniar HS, Passeri JJ, Investigators PARTNER. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of aortic transcatheter valves (PARTNER) trial (cohort A), Circ Cardiovasc. Interv. 2013;6(6):604–14. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000650CrossRef Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, Douglas PS, Fearon WF, Kirtane AJ, Maniar HS, Passeri JJ, Investigators PARTNER. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of aortic transcatheter valves (PARTNER) trial (cohort A), Circ Cardiovasc. Interv. 2013;6(6):604–14. https://​doi.​org/​10.​1161/​CIRCINTERVENTION​S.​113.​000650CrossRef
17.
go back to reference Sannino A, Gargiulo G, Schiattarella GG, Brevetti L, Perrino C, Stabile E, Losi MA, Toscano E, Giugliano G, Scudiero F, Chiacchio E, Trimarco B, Esposito G. Increased mortality after transcatheter aortic valve implantation (TAVR) in patients with severe aortic stenosis and low ejection fraction: a meta-analysis of 6898 patients. Int J Cardiol. 2014;176(1):32–9. Epub 2014 Jun 27. PMID: 25042666.CrossRefPubMed Sannino A, Gargiulo G, Schiattarella GG, Brevetti L, Perrino C, Stabile E, Losi MA, Toscano E, Giugliano G, Scudiero F, Chiacchio E, Trimarco B, Esposito G. Increased mortality after transcatheter aortic valve implantation (TAVR) in patients with severe aortic stenosis and low ejection fraction: a meta-analysis of 6898 patients. Int J Cardiol. 2014;176(1):32–9. Epub 2014 Jun 27. PMID: 25042666.CrossRefPubMed
18.
go back to reference Eleid MF, Goel K, Murad MH, Erwin PJ, Suri RM, Greason KL, Nishimura RA, Rihal CS, Holmes DR Jr. Meta-analysis of the prognostic impact of stroke volume, gradient, and Ejection Fraction after Transcatheter aortic valve implantation. Am J Cardiol. 2015;116(6):989–94. Epub 2015 Jun 26. PMID: 26195275.CrossRefPubMed Eleid MF, Goel K, Murad MH, Erwin PJ, Suri RM, Greason KL, Nishimura RA, Rihal CS, Holmes DR Jr. Meta-analysis of the prognostic impact of stroke volume, gradient, and Ejection Fraction after Transcatheter aortic valve implantation. Am J Cardiol. 2015;116(6):989–94. Epub 2015 Jun 26. PMID: 26195275.CrossRefPubMed
19.
go back to reference Schaefer UZR, et al. Comparison of outcomes of patients with left ventricular ejection fractions ≤ 30% versus ≥ 30% having transcatheter aortic valve implantation (from the German transcatheter aortic valve interventions Registry). Am J Cardiol. 2015;115:656–63.CrossRefPubMed Schaefer UZR, et al. Comparison of outcomes of patients with left ventricular ejection fractions ≤ 30% versus ≥ 30% having transcatheter aortic valve implantation (from the German transcatheter aortic valve interventions Registry). Am J Cardiol. 2015;115:656–63.CrossRefPubMed
21.
go back to reference Baron SJ, et al. Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2349–58.CrossRefPubMedPubMedCentral Baron SJ, et al. Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2349–58.CrossRefPubMedPubMedCentral
Metadata
Title
Outcomes in patients with aortic stenosis and severely reduced ejection fraction following surgical aortic valve replacement and transcatheter aortic valve replacement
Authors
Eric R. Bain
Bistees George
Syed H. Jafri
Roopa A. Rao
Anjan K. Sinha
Maya E. Guglin
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2024
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-024-02724-9

Other articles of this Issue 1/2024

Journal of Cardiothoracic Surgery 1/2024 Go to the issue